Karyopharm Therapeutics(KPTI) - 2023 Q4 - Earnings Call Presentation

Fourth Quarter and Full Year 2023 Financial Results & Business Update • Welcome Elhan Webb, CFA, Senior Vice President, Investor Relations • Overview Dr. Reshma Rangwala, Chief Medical Officer • Commercial Highlights Richard Paulson, President and Chief Executive Officer • Q&A Session XPOVIO® (selinexor) and NEXPOVIO® (selinexor) are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this presentation are the property of their respective owners. All rights reserved. 3 ...